Sign in | Join | Help

The Stock Playbook » All Tags » Options » (CELG) (

RSS)

Browse by Tags

The Stock Playbook

Join InvestorsInsight Today!

FREE EverBank World Market Report

To download your free report on today's world market, complete the sign up form below.

Sign in name:

Choose Password:

Email Address:

(your email address is not published)

Allow this site to contact me:

Allow this site's partners to contact me:

Subscribe to Dave's Blog

RSS for Posts
Atom
RSS for Comments
Enter Your Email Address:
SEND

Syndication

Recent Posts

Issue: 3/19/2008

Tags

Archives

Issue: 3/19/2008

The Playbook 100 CELG @ $57.68 (Celgene) develops therapies to treat cancer and immune-inflammatory related diseases. Revenues have increased between 43% and 76% during each of the last four quarters. Earnings have increased between 72% and 136% during...

Published Wed, Mar 03 2008 3:01 PM by Dave Dispennette

Filed under: IPO's, New Issues, Options, The Playbook 100, ETF's, (FXI), (CELG), (V)

© 2003-2008 InvestorsInsight Publishing, Inc.

Investor Blogs

John Mauldin's Thoughts From The Frontline
John Mauldin's Outside The Box
Forecasts & Trends by Gary D. Halbert
Daily Pfennig by Chuck Butler
Musing on the Markets by Vinny Catalano, CFA

Richard Schwartz's Principles of the Stock Market
The Options Report with Ken Trester
The Stock Playbook with Dave Dispennette
The Room with David Galland
The Opinionator with Shannara Johnson

Useful Links

Advertise
Privacy Policy
Legal Statement
Who Is Online
Help